Ravat Panvichian

453 total citations
18 papers, 356 citations indexed

About

Ravat Panvichian is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ravat Panvichian has authored 18 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ravat Panvichian's work include HER2/EGFR in Cancer Research (5 papers), Molecular Biology Techniques and Applications (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Ravat Panvichian is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Molecular Biology Techniques and Applications (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Ravat Panvichian collaborates with scholars based in Thailand, United States and Bangladesh. Ravat Panvichian's co-authors include Surasak Leelaudomlipi, Napat Angkathunyakul, Kenneth J. Pienta, Mark L. Day, Kim Orth, Mary Jo Pilat, Kathleen C. Day, Touch Ativitavas, T. Sirisinha and Ekaphop Sirachainan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and BioMed Research International.

In The Last Decade

Ravat Panvichian

18 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravat Panvichian Thailand 11 192 130 88 79 59 18 356
Sang Hyun Song South Korea 10 242 1.3× 82 0.6× 43 0.5× 59 0.7× 21 0.4× 22 396
Zhongqin Gong China 11 195 1.0× 90 0.7× 59 0.7× 119 1.5× 22 0.4× 16 345
Liz J. Hernández Borrero United States 2 260 1.4× 136 1.0× 68 0.8× 120 1.5× 15 0.3× 2 441
Norifumi Kanai Japan 6 141 0.7× 147 1.1× 25 0.3× 37 0.5× 24 0.4× 15 347
Xuan Zhu China 15 339 1.8× 91 0.7× 43 0.5× 273 3.5× 17 0.3× 28 519
Eliene Bogaerts Belgium 12 208 1.1× 74 0.6× 30 0.3× 77 1.0× 23 0.4× 17 519
Michael H. Wu United States 8 224 1.2× 180 1.4× 101 1.1× 56 0.7× 55 0.9× 8 390
Ewoud N. Speksnijder Netherlands 11 288 1.5× 223 1.7× 36 0.4× 125 1.6× 36 0.6× 15 470

Countries citing papers authored by Ravat Panvichian

Since Specialization
Citations

This map shows the geographic impact of Ravat Panvichian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravat Panvichian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravat Panvichian more than expected).

Fields of papers citing papers by Ravat Panvichian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravat Panvichian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravat Panvichian. The network helps show where Ravat Panvichian may publish in the future.

Co-authorship network of co-authors of Ravat Panvichian

This figure shows the co-authorship network connecting the top 25 collaborators of Ravat Panvichian. A scholar is included among the top collaborators of Ravat Panvichian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravat Panvichian. Ravat Panvichian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Charoenyingwattana, Angkana, Thitiporn Suwatanapongched, Phichai Chansriwong, et al.. (2022). Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer. BMC Cancer. 22(1). 963–963. 9 indexed citations
2.
Panvichian, Ravat, et al.. (2021). PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues. BMC Cancer. 21(1). 295–295. 11 indexed citations
3.
Panvichian, Ravat, et al.. (2020). HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant. Cell & Bioscience. 10(1). 41–41. 34 indexed citations
4.
Panvichian, Ravat, et al.. (2018). Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues. Medical Oncology. 35(12). 149–149. 10 indexed citations
5.
Panvichian, Ravat, et al.. (2018). Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues. Medical Oncology. 35(10). 127–127. 13 indexed citations
6.
Panvichian, Ravat, et al.. (2015). TOP2A Amplification and Overexpression in Hepatocellular Carcinoma Tissues. BioMed Research International. 2015. 1–8. 89 indexed citations
7.
Panvichian, Ravat, et al.. (2015). Missense Mutations in Exons 18–24 of EGFR in Hepatocellular Carcinoma Tissues. BioMed Research International. 2015. 1–7. 12 indexed citations
8.
Panvichian, Ravat, et al.. (2012). HER2 Expression in Breast Cancer With Nonamplified HER2 and Gains of Chromosome 17 Centromere. Applied immunohistochemistry & molecular morphology. 20(4). 367–374. 3 indexed citations
9.
Sirachainan, Ekaphop, Monpat Chamnanphon, T. Sirisinha, et al.. (2012). Impact of CYP2D6 Polymorphisms on Tamoxifen Responses of Women with Breast Cancer: A Microarray-based Study in Thailand. Asian Pacific Journal of Cancer Prevention. 13(9). 4549–4553. 35 indexed citations
10.
Sirachainan, Ekaphop, et al.. (2012). CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients. SHILAP Revista de lepidopterología. 5. 149–149. 27 indexed citations
11.
Ativitavas, Touch, et al.. (2011). Cytochrome P450 2D6 polymorphisms of Thai patients with breast cancer and their outcomes of adjuvant tamoxifen.. Journal of Clinical Oncology. 29(15_suppl). e11037–e11037. 4 indexed citations
12.
Panvichian, Ravat, et al.. (2010). Assessment of the Relationship Between RNA Integrity and Post-Chip QC Variables of Affymetrix GeneChip Human Genome U133 Plus 2.0 Array Experiments. 28(2). 74–82. 1 indexed citations
13.
Panvichian, Ravat, et al.. (2007). Fluorescence in situ hybridization method in isolated single nuclei extracted from paraffin-embedded hepatocellular carcinoma tissues.. PubMed. 90(2). 363–8. 4 indexed citations
14.
Panvichian, Ravat, et al.. (2006). Acute deterioration of renal function induced by star fruit ingestion in a patient with chronic kidney disease. Journal of Nephrology. 19(5). 682–686. 22 indexed citations
15.
Panvichian, Ravat, Kim Orth, Mary Jo Pilat, et al.. (1999). Signaling network of paclitaxel-induced apoptosis in the LNCaP prostate cancer cell line. Urology. 54(4). 746–752. 12 indexed citations
16.
Panvichian, Ravat, Kim Orth, Mark L. Day, et al.. (1998). Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance.. PubMed. 58(20). 4667–72. 63 indexed citations
17.
Panvichian, Ravat & Kenneth J. Pienta. (1996). The treatment of hormone refractory prostate cancer.. PubMed. 22(2). 81–7. 5 indexed citations
18.
Panvichian, Ravat & Kenneth J. Pienta. (1996). Hormonal and Chemotherapeutic Systemic Therapy for Metastatic Prostate Cancer. Cancer Control. 3(6). 493–500. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sang Hyun Song Breakdown of academic impact, for papers by Zhongqin Gong Breakdown of academic impact, for papers by Liz J. Hernández Borrero Breakdown of academic impact, for papers by Norifumi Kanai Breakdown of academic impact, for papers by Xuan Zhu Breakdown of academic impact, for papers by Eliene Bogaerts Breakdown of academic impact, for papers by Michael H. Wu Breakdown of academic impact, for papers by Ewoud N. Speksnijder
Rankless by CCL
2026